Breakthrough Discovery Unveils Major Cause of Inflammatory Bowel Disease

UK scientists have identified a genetic weak spot present in 95% of people with inflammatory bowel disease (IBD), which causes immune cells to drive excessive inflammation in the bowels. Existing drugs have shown promise in reversing the disease in lab experiments, and researchers aim to start human trials within five years. This discovery could lead to new treatments for conditions like Crohn's disease and ulcerative colitis, which affect around half a million people in the UK.